The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 28, 2024
Filed:
May. 24, 2021
Applicant:
Fred Hutchinson Cancer Center, Seattle, WA (US);
Inventors:
Stanley R. Riddell, Sammamish, WA (US);
Lingfeng Liu, Seattle, WA (US);
Assignee:
Fred Hutchinson Cancer Center, Seattle, WA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 35/17 (2015.01); A61K 35/545 (2015.01); A61K 38/20 (2006.01); C07K 14/705 (2006.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01); C07K 19/00 (2006.01); C12N 5/0783 (2010.01); G01N 33/569 (2006.01); A61K 35/12 (2015.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 35/17 (2013.01); A61K 35/545 (2013.01); A61K 38/1774 (2013.01); A61K 38/2013 (2013.01); A61K 38/2086 (2013.01); C07K 14/705 (2013.01); C07K 14/7051 (2013.01); C07K 14/70521 (2013.01); C07K 14/70578 (2013.01); C07K 16/2818 (2013.01); C07K 16/2878 (2013.01); C12N 5/0637 (2013.01); C12N 5/0638 (2013.01); G01N 33/56972 (2013.01); A61K 2035/124 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/622 (2013.01); C07K 2317/64 (2013.01); C07K 2319/03 (2013.01); C07K 2319/20 (2013.01); C07K 2319/22 (2013.01); C07K 2319/33 (2013.01); C07K 2319/95 (2013.01); C12N 2501/2302 (2013.01); C12N 2510/00 (2013.01);
Abstract
The present disclosure relates to tagged chimeric effector molecules and receptor molecules thereof for genetically engineering a host cell, wherein the recombinant host cell can be identified, isolated, sorted, induced to proliferate, tracked or eliminated. For example, a T cell may be recombinantly modified for use in adoptive immunotherapy.